Mechanisms for the induction of autoimmunity by infectious agents.

Activation and clonal expansion of autoreactive lymphocytes is a critical step in the pathogenesis of autoimmune diseases. In experimental models of autoimmunity, disease can be transferred by activated, but not resting, autoreactive T cells (1), indicating that activation of autoreactive T cells is required for the development of autoimmune diseases. Infectious agents have long been considered as possible culprits in the activation of autoreactive T cells. Mechanisms by which an infection can lead to an autoimmune process have been examined in experimental animal models, and these concepts as well as their relevance to human diseases will be discussed here.

[1]  Bernhard Hemmer,et al.  Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone , 1997, The Journal of experimental medicine.

[2]  J. Meulstee,et al.  Cytomegalovirus infection and Guillain-Barre syndrome , 1996, Neurology.

[3]  N. Gt.  MHC and autoimmune diseases. , 1993 .

[4]  P. Wu,et al.  A single nonamer from the Yersinia 60-kDa heat shock protein is the target of HLA-B27-restricted CTL response in Yersinia-induced reactive arthritis. , 1997, Journal of immunology.

[5]  J. Penninger,et al.  Chlamydia infections and heart disease linked through antigenic mimicry. , 1999, Science.

[6]  L. Steinman,et al.  Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.

[7]  S. Miller,et al.  Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading , 1997, Nature Medicine.

[8]  I. Wilson,et al.  The CD1 family of lipid antigen-presenting molecules. , 1998, Immunology today.

[9]  E. Sercarz,et al.  Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen , 1992, Nature.

[10]  A. Steere,et al.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.

[11]  B. Cole,et al.  Triggering and exacerbation of autoimmune arthritis by the Mycoplasma arthritidis superantigen MAM. , 1993, Arthritis and rheumatism.

[12]  K. Wucherpfennig.  Structural basis of molecular mimicry. , 2001, Journal of autoimmunity.

[13]  M. Blaser,et al.  Epidemiologic and clinical features of Campylobacter jejuni infections. , 1997, The Journal of infectious diseases.

[14]  S. Kaufmann,et al.  Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. , 1999, Immunity.

[15]  B. Fleischer,et al.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis , 1993, The Lancet.

[16]  C. López-Larrea,et al.  The role of HLA-B27 polymorphism and molecular mimicry in spondylarthropathy. , 1998, Molecular medicine today.

[17]  M. Kronenberg,et al.  The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen. , 2001, Immunity.

[18]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[19]  L. Steinman,et al.  The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.

[20]  F. Granucci,et al.  Analysis of the relationship between viral infection and autoimmune disease. , 2001, Immunity.

[21]  A. Moran,et al.  Structure and conserved characteristics of Campylobacter jejuni lipopolysaccharides. , 1997, The Journal of infectious diseases.

[22]  J. Soos,et al.  Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis , 1993, Journal of Neuroimmunology.

[23]  R. Hammer,et al.  Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β 2m: An animal model of HLA-B27-associated human disorders , 1990, Cell.

[24]  John A Todd,et al.  Genetic Analysis of Autoimmune Disease , 1996, Cell.

[25]  P. Marrack,et al.  Superantigens: bacterial and viral proteins that manipulate the immune system. , 1993, Annual review of cell biology.

[26]  Y. Hsu.  ASSOCIATION OF CHRONIC LYME ARTHRITIS WITH HLA-DR4 and HLA-DR2 ALLELES: , 1991 .

[27]  G. Stollerman.  RHEUMATIC FEVER , 1947, A.M.A. archives of internal medicine.

[28]  A. Steere,et al.  Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. , 1999, Arthritis and rheumatism.

[29]  R. Fujinami,et al.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.

[30]  J. Zabriskie,et al.  Rheumatic fever and poststreptococcal reactive arthritis. , 1995, Current opinion in rheumatology.

[31]  C. Ferri,et al.  Relation between infection and autoimmunity in mixed cryoglobulinemia. , 2000, Current opinion in rheumatology.

[32]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[33]  M. Ho,et al.  Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. , 1989, Journal of immunology.

[34]  A. Steere,et al.  Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis. , 1999, Arthritis and rheumatism.

[35]  R. Hammer,et al.  The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats , 1994, The Journal of experimental medicine.

[36]  G. Nepom.  MHC and autoimmune diseases. , 1993, Immunology series.

[37]  Don C. Wiley,et al.  Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein , 1998, The Journal of experimental medicine.

[38]  H Cantor,et al.  Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. , 1998, Science.

[39]  Jean Côté,et al.  Lyme Disease , 1991, International journal of dermatology.

[40]  H. Obayashi,et al.  Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.

[41]  E. Märker-Hermann,et al.  Pathogenesis of human leukocyte antigen B27-positive arthritis. Information from clinical materials. , 1998, Rheumatic diseases clinics of North America.

[42]  R. Pedotti,et al.  Clinical presentation and outcome of Guillain–Barré and related syndromes in relation to anti-ganglioside antibodies , 1999, Journal of the Neurological Sciences.

[43]  M. Blaser,et al.  Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China , 1993, Annals of neurology.

[44]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[45]  R. Henderson,et al.  Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.

[46]  R. Hughes,et al.  Clinical and epidemiologic features of Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.

[47]  K. Wucherpfennig,et al.  Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. , 1999, Journal of immunology.

[48]  J. Meulstee,et al.  Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group. , 1996, Neurology.